The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effect of RAS on anti-EGFR monoclonal antibodies plus 5-FU infusion-based chemotherapy in first-line treatment of metastatic colorectal cancer: A meta-analysis.
Mingyi Zhou
No relevant relationships to disclose
Ping Yu
No relevant relationships to disclose
Kezuo Hou
No relevant relationships to disclose
Bo Jin
No relevant relationships to disclose
Xiujuan Qu
No relevant relationships to disclose
Yunpeng Liu
No relevant relationships to disclose
Yunpeng Liu
No relevant relationships to disclose
Jingdong Zhang
No relevant relationships to disclose